REGN7999
R7999-BThal-2350
Phase 2 small_molecule active
Quick answer
REGN7999 for Non-Transfusion Dependent Beta-Thalassemia (NTDT) is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Non-Transfusion Dependent Beta-Thalassemia (NTDT)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active